Company Filing History:
Years Active: 2008-2022
Title: Naoya Hoshino: Innovator in Transdermal Pharmaceutical Composition
Introduction
Naoya Hoshino is a notable inventor based in Japan, recognized for his contributions to the field of pharmaceuticals. His work primarily focuses on developing innovative compositions for transdermal and transmucosal administration. Hoshino's inventions aim to improve the delivery of therapeutic agents, particularly for conditions such as Alzheimer's and Parkinson's diseases.
Latest Patents
Hoshino holds a patent for a transdermal or transmucosal pharmaceutical composition comprising 1-(benzofuran-2-yl)-2-propylaminopentane. This invention provides a composition that is useful as an anti-Alzheimer's drug, an antiparkinson drug, an antidepressant, a psychoactive drug, or a therapeutic agent for drug dependence. The composition allows for effective delivery of the active ingredient through the skin and mucous membranes, avoiding the first-pass effect in the liver and minimizing discomfort associated with traditional administration methods.
Career Highlights
Hoshino is associated with Fujimoto Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has the potential to significantly impact the treatment of various neurological and psychological conditions. Despite having no patents listed under his name, his research and development efforts contribute to the advancement of medical therapies.
Collaborations
Hoshino has collaborated with notable colleagues such as Fumio Yoneda and Hironori Ohde. Their combined expertise enhances the research and development processes at Fujimoto Co., Ltd.
Conclusion
Naoya Hoshino's work in transdermal pharmaceutical compositions represents a significant advancement in drug delivery systems. His innovative approach aims to improve patient outcomes in the treatment of serious health conditions.